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ABSTRACT 
Brihathyadi kashayam mentioned in Yogarathnakara in the treatment of Mootrkrichra consists of 
combination of five simple drugs which are Brihathi, Prishnaparni, Kutaja, Paata, and Yasthimadhu. 
That is found to be more effective and safe in the treatment of Mutravahasrotovikaras. Aim and 
Objectives: Evaluation of Analytical study and the nephroprotective effect of Brihathyadi 
kashayam. Objectives: To prepare Brihathyadi kashayam according to classical reference, 
Experimental evaluation of Brihathyadi kashayam for its nephroprotective activity. Materials and 
Methods: Brihathyadi kashayam lower dose and higher dose were used in the study of 
nephroprotective activity in albino rats. The nephroprotective activity of Brihathyadi kashayam 
were evaluated against Rifampicin induced renal damage in albino rats. The results were analyzed 
by statistical methods. Results: In the experimental study the result was showed as the Brihathyadi 
Kashayam double dose was found effective in nephroprotective action, i.e., in reversing the 
degenerative changes caused in the nephrons by Rifampicin and lowering the serum creatinine, 
uric acid and urea levels comparing with the Brihathyadi Kashayam single dose and disease 
controlled group. Conclusion: This experimental study of Brihathyadi kashayam double dose 
showed the nephroprotective activity against the Rifampicin induced renal damage. 
KEYWORDS: Brihathyadi kashayam, Mutravaha sroto vikaras, Nephroprotective activity. 
INTRODUCTION 
Ayurveda, the science of life is traced back to 
Vedic time about 5000 B.C and is widely practiced 
throughout India. The Ayurvedic methods of holistic 
health care emphasizes balancing the body, mind and 
spirit to treat and prevent disease[1]. The main 
objectives of Ayurveda is “Swasthasya swasthya 
rakshanam aturasya vikara prashamanam” that 
means to protect and maintain the health of a healthy 
person and to treat the disease and giving relief to 
sick person [2]. 
Srotas are the channels that convey the body 
elements, which are undergoing metabolic processes, 
sub serve the purpose of circulation. The vitiation, 
depletion and maintenance of existed bodily 
structures are never possible without Srothas[3]. All 
the Brihatrayees were explained about Srotas in the 
respective Samhitas. 
Mootravaha srotas is one among the thirteen 
Srotases and is having its predominant action in 
Kledavahana[4]. Being a system responsible for 
homeostasis of fluids in the body it also detoxifies by 
eliminating the waste products through urine[5]. 
Mootravahasrotovikaras and its treatment are 
mentioned in Samhithas. As Basthi is one among the 
Trimarms[6] prime importance should be given in the 
treatment of Mutravaha sroto vikaras. 
Renal dysfunction is one of the common 
conditions in population. Recent statistical study 
shows that the 17% of Indians having the Kidney 
related disease and the majority of the patients are 
belongs to the younger and predominantly in 
working population [7]. Current line of treatments for 
impaired renal function in modern medicine are 
Antihypertensive, Diuretics, and Erythropoietin etc. 
Dialysis and organ transplantations are the late stage 
managements[8]. It is costly and also has its own 
known potential adverse effects[9]. 
Brihathyadi kashayam mentioned in 
Yogarathnakara in the treatment of Mootrkrichra 
consists of combination of five simple drays which 
are Brihathi, Prishnaparni, Kutaja, Paata, and 
Yasthimadhu[10]. That is found to be more effective 
and safe in the treatment of Mutravaha srotovikaras. 
However clinically Brihathyadi kashayam is 
widely used in the treatment of Mootravaha 
srotovikaras without any adverse effects, but in 
present era, experimental and clinical study with 
statistical analysis is necessary to scientifically prove 
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the same. Here an attempt is made to study the 
efficacy of this safe and economic combination in 
albino rats for its nephron– protective action.  
MATERIALS AND METHODS 
The test drug was prepared from Rasa 
Shastra & Bhaishajya Kalpana department Rasashala 
of Ramakrishna Ayurvedic Medical College, 
Yelahanka, Bangalore. All the Chemical reagents and 
other requirements of experimental study used from 
stock of Invivo Biosciences, # 23, Katha No 3169, 
Assessment No 154, Kodigehalli Village, off Magadi 
road, Yeshwanthapur, Hobli, Bengaluru North Taluk, 
Bengaluru. 
The drug which used as standard drug i.e., 
Cystone Manufactured by Himalaya Drug Company 
purchased from Himalaya Health and beauty shop, 
#739/2, 4th phase Main road, Opp: A.I.R Quarters, 
Yelahanka New town, Bengaluru. The drug which 
used to induce nephrotoxicity i.e., Rifampicin 
purchased from NRR hospital, No 3 & 3A, 
Hesarghatta Main road, Chikkasandra, Jalahalli West, 
Bengaluru. Swiss albino rats of either sex weighing 
between 200-250gm were used for the study. 
Animals were produced from animal house. Twenty 
four Albino rats were selected and allotted to four 
groups of six rats in each group. Six rats were housed 
in each cage made up of poly-propylene with 
stainless top grill. The husk was used as bedding 
material and was changed frequently to protect from 
infections. Animals were maintained at standard 
laboratory conditions such as temperature at 23 to 
240C, humidity of 48-63% and 12 hr light and dark 
cycles. Animals were fed with standard pellet feed 
supplied by VRK nutrition solution and aqua guard 
water in polypropylene bottles. The Animal Ethical 
committee has approved for experimentation on 
Animals (Approval number-Invivo-089). 
Table 1: Grouping of Experimental Animals 
Group1  Disease control Rifampicin (1g/kg) 
Group2 Positive control Cystone (750mg/k) 
Group3 Single dose Brihatyadi kashayam 
(10ml/kg) 
Group4 Double dose Brihatyadi kashayam 
(20ml/kg) 
Animals were grouped into different 
categories as mentioned above. All the animals will 
be administered with Rifampicin at the dose of 1g/kg 
body weight through orally with the help of feeding 
syringe for a period of 14 days with the interval of 72 
hour to induce renal failure i.e., on the 4th, 7th, 10th, 
13th days. Standard drug and test drugs administered 
for 15 consecutive days in their respective doses. 
After dosing, body weight, feed intake and urine 
output were measured. On 15th day blood was 
collected from retro-orbital puncture from the albino 
rats under anaesthetic condition. Biochemical 
parameters were Serum analysis (Urea, Creatinine, 
Nitrogen, Uric acid), Histopathology of kidney, 
animals were sacrificed and kidney tissue was 
collected 10% formalin used for histopathological 
examination. 
Average of all the data was compiled and SEM 
were calculated. The biochemistry of treated groups 
was compared with negative control groups by one-
way anova followed by dunnett’s multiple 
comparison test. 
RESULTS 
The effect of the drugs in Serum Creatinine is dominated in the table below.  
Table 2: Effect of Test Drugs in Serum Creatinine 
S.No Group Creatinine 
(mg/dl) 
1. Disease control 2.140 ± 0.082 
2. Positive control 1.105 ± 0.059 
3. Brihathyadi Kashayam Single dose 1.508 ± 0.051 
4. Brihathyadi Kashayam Double dose 1.340 ± 0.047 
DATA: MEAN ± SEM 
The data related to the effect of Brihathyadi Kashayam Single dose and Brihathyadi Kashayam double dose on 
the Serum Creatinine have been depicted in the table. 
The data shows there was reduction in the Serum Creatinine when compared against Disease controlled group 
which is statistically significant.  
The effect of the drugs in Uric acid is dominated in the table below.  
 
 
Binu.M.B et al. Nephroprotective Activity of Brihathyadi Kashayam In Albino Rats  
     IJAPR | November 2020 | Vol 8 | Issue 11  9 
Table 3: Effect of Test Drugs in Uric Acid 
Group Uric acid 
(mg/dl) 
Disease control 1.912 ± 0.066 
Positive control 0.707 ± 0.047 
Brihathyadi Kashayam Single dose 1.110 ± 0.042 
Brihathyadi Kashayam Double dose 0.963 ± 0.057 
DATA: MEAN ± SEM 
The data related to the effect of Brihathyadi Kashayam Single dose and Brihathyadi Kashayam double 
dose on the Uric acid have been depicted in the table. 
The data shows there was reduction in the Uric acid when compared against Disease controlled group 
which is statistically significant. The effect of the drugs in Urea nitrogen is dominated in the table below.  
Table 4: Effect of Test Drugs in Urea Nitrogen 
Group Urea nitrogen (mg/dl) 
Disease control 38.47 ± 0.510 
Positive control 17.62 ± 0.429 
Brihathyadi Kashayam Single dose 26.87 ± 0.304 
Brihathyadi Kashayam Double dose 24.250 ± 0.580 
DATA: MEAN ± SEM 
The data related to the effect of Brihathyadi Kashayam Single dose and Brihathyadi Kashayam double 
dose on the Urea level have been depicted in the table. 
The data shows there was reduction in the Uric acid when compared against Disease controlled group 
which is statistically significant. The effect of the drugs in body weight is dominated in the table below.  
Table 5: Effect of Test Drugs in Body Weight 
Group body weight 
in gm Day 1 
body weight 
in gm Day 14 
Disease control 234.7 ± 1.1 275.0 ± 1.4 
Positive control 236.0 ± 0.6 277.0 ± 2.4 
Brihathyadi Kashayam Single dose 234.8 ± 0.9 277.0 ± 1.2 
Brihathyadi Kashayam Double dose 235.3 ± 0.7 277.7 ± 1.2 
DATA: MEAN ± SEM 
The data related to the effect of Brihathyadi Kashayam Single dose and Brihathyadi Kashayam double 
dose on the Body weight have been depicted in the table. There was no significant change observed in the body 
weight. The effect of the drugs in weight of Kidney is dominated in the table below.  
Table 6: Effect of Test Drugs on Weight of Kidney 
Group Kidney weight in 
mg 
Disease control 414 ± 3.9 
Positive control 326 ± 1.1 
Brihathyadi Kashayam Single dose 384.5 ± 8.5 
Brihathyadi Kashayam Double dose 342.0 ± 8.3 
DATA: MEAN ± SEM 
The data related to the effect of Brihathyadi Kashayam Single dose and Brihathyadi Kashayam double 
dose on the weight of Kidney have been depicted in the table. There was dose dependent reduction in kidney 
weight when compared against Disease controlled group which is statistically significant. 
The effect of the drugs in Urine outputs dominated in the table below.  
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Table 7: Effect of Test Drugs in Urine Output 
Group Urine output in ml 
Disease control 5.7 ± 0.3 
Positive control 7.7 ± 0.3 
Brihathyadi Kashayam Single dose 6.7 ± 0.3 
Brihathyadi Kashayam Double dose 7.5 ± 0.4 
DATA: MEAN ± SEM 
The data related to the effect of Brihathyadi Kashayam Single dose and Brihathyadi Kashayam double 
dose on the Urine output have been depicted in the table. There was marked increase in urine output in High 
dose of sample drug when compared against Disease controlled, which is statistically significant. 
The effect of the drugs in Feed intake is dominated in the table below.  
Table 8: Effect of Test Drugs in Feed Intake 
Group Feed intake per 
animals in gm 
Disease control 12.5 
Positive control 13.5 
Brihathyadi Kashayam Single dose 13.3 
Brihathyadi Kashayam Double dose 14.2 
The data related to the effect of Brihathyadi 
Kashayam Single dose and Brihathyadi Kashayam 
double dose in the feed intake have been depicted in 
the table. There was dose dependent increase in feed 
intake when compared against Disease controlled 
group.  
DISCUSSION 
Brihathyadi kashayam mentioned in 
Yogarathnakara in the treatment of Mootrkrichra 
consists of combination of five drugs which are 
Brihathi, Prishnaparni, Kutaja, Paata, and 
Yasthimadhu. With the classical preparation as well 
as the properties of the drug and the combination 
shows the Mutrala property. The Kashaya Thiktha 
rasa of the Brihathyadi kashayam, it can act as 
Vatanulomka and and Srothoshodhaka by 
Kledhasamana. As Brihathyadi kashayam is indicated 
in the Mutravaha srotovikaras the attempt is done to 
evaluate its nephroprotective effect. 
In the present study significant level of Serum 
Creatinine, Uric acid, Urea nitrogen, cell structural 
changes and interstitial oedema was noted in 
Rifampicin administered group, indicate the renal 
dysfunction which got apparently reversed by 
Brihathyadi Kashayam double dose which was 
statistically significant. 
In the present study Rifampicin administration 
caused significant elevation in the Serum Creatinine, 
Uric acid and Urea level. This indicates the Rifampicin 
administration caused renal toxicity. The Rifampicin 
induced nephro toxicity was significantly reversed by 
the Brihathyadi Kashayam double dose hence by the 
support of analytical and experimental evidence 
Brihathyadi Kashayam double dose was proven for its 
nephro-protective activity.  
CONCLUSION 
In the experimental study that was carried 
out to evaluate the nephro-protective activity of 
Brihathyadi Kashayam in albino rats was found 
effective in nephro-protective action, i.e, in reversing 
the degenerative changes caused in the nephrons by 
Rifampicin. Brihathyadi Kashayam sample is effective 
in reversing the induced degenerative changes in 
nephrons of albino rats. By the virtue of the Mutrala 
property and Kashaya– Tiktha rasa the drug 
Brihathyadi Kashayam is known to act as nephron-
protective. On the observation of Experimental study 
data and Histopathological reports showed the result 
of the activity ie, Brihathyadi Kashayam double dose 
act as nephro protective. 
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Pictures of Experimental Study 
  
Image 1: Animal grouping  Image 2: Animals feeding 
  
Image 3: Brihathyadi Kashayam Preparation Image 4: Brihathyadi Kashayam 
  
Image 5: Animal dosing  Image 6: urine collection 
  
Image 7: Blood sample collection Image         8: Dissected organ 
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Histopathology 
 
Image 9: Histopathology of Kidney 
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